Nova Patents
BRPI0807857A2

Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus

Abstract

This record has no abstract on file.

Term

Projected expiry 25 January 2028.

  1. Priority
  2. Filed
  3. Granted
  4. Today
  5. Projected expiry

33 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims14

Priority claims
DocumentOfficeKindDate
074470063European Patent Office (EPO)–
07447006European Patent Office (EPO)A
07447006European Patent Office (EPO)A
071127922European Patent Office (EPO)–
07112792European Patent Office (EPO)A
07112792European Patent Office (EPO)A
2008050900European Patent Office (EPO)W
2008050900European Patent Office (EPO)W
071127922–––
074470063–––
2008050900–––
EP20070112792–––
EP20070447006–––
WO2008EP50900–––

Members33

Family members, oldest first
DocumentOfficeKind
CA2675297A1CanadaA1
CA3037889A1CanadaA1
WO2008090223A2World Intellectual Property Organization (WIPO)A2
WO2008090223A3World Intellectual Property Organization (WIPO)A3
EP2125010A2European Patent Office (EPO)A2
CN101605559AChinaA
US2010104601A1United States of AmericaA1
JP2010516269AJapanA
US2013095129A1United States of AmericaA1
US8524246B2United States of AmericaB2
US2013330374A1United States of AmericaA1
CN101605559BChinaB
BRPI0807857A2This recordBrazilA2
EP2125010B1European Patent Office (EPO)B1
CN103933563AChinaA
DK2125010T3DenmarkT3
ES2492468T3SpainT3
EP2774621A2European Patent Office (EPO)A2
EP2774621A3European Patent Office (EPO)A3
CN103933563BChinaB
EP2774621B1European Patent Office (EPO)B1
DK2774621T3DenmarkT3
ES2666658T3SpainT3
EP3351268A1European Patent Office (EPO)A1
US10143729B2United States of AmericaB2
US2019076511A1United States of AmericaA1
CA2675297CCanadaC
HK1258000AHong Kong, ChinaA
HK1258000A1Hong Kong, ChinaA1
US10668136B2United States of AmericaB2
EP3351268B1European Patent Office (EPO)B1
DK3351268T3DenmarkT3
CA3037889CCanadaC